Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Executive Summary

HOSPITAL/COMMUNITY PHARMACIST SHARING OF EXPERTISE could improve overall patient care, APhA President Jack Schlegel urged in an Oct. 11 address to the Maryland Society of Hospital Pharmacists, in Baltimore. He suggested that not only should community pharmacists, under APhA's plan to develop residencies, have some training in the hospital environment, but that hospital-pharmacist residents should spend some time in the community pharmacy. Suggesting a need for "complementary roles" by hospital and community pharmacists in monitoring drug therapy for outpatients and providing services for home care, Schlegel urged: "We all must work diligently to remove the clinical versus traditional pharmacy attitude and reality. Clinical means patient care, and that is what our profession is all about." Schlegel asked the hospital pharmacists "to work with us as we work toward raising the level of pharmacy practice and offer all pharmacists opportunities to rise above what some refer to as counting and pouring functions." He added: "You who are privileged to work in institutions where you do have sophisticated programs, where the use of new technologies is at its highest and where opportunities for education and training abound, must share your experiences, resources, and expertise with pharmacists practicing in other settings." Pharmacist-sharing of experiences and expertise was seen by the APhA president "as essential to advancing our profession as a whole. To isolate small segments of the profession can only weaken our position wherever we must make a stand." Day-to-day experience of clinical practitioners in working more closely with patients, MDs and other providers "has shown the way for their colleagues," Schlegel declared, admonishing: "But you who are clinical pharmacists must now come out of splendid institutional isolation and take leadership in the profession to implement clinical practice in the community practice setting. Clinical pharmacy practice -- with all its specialties -- should not be unique to only a few. We are first pharmacists; all else follows."

You may also be interested in...

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts